CHI Advisors LLC

SEC CIK: 0001791468
Latest filing: Nov 13, 2023

SEC filings (opens in a new tab)

RARE holding history

Ultragenyx Pharmaceutical Inc. in every 13F filed by CHI Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RARE overview All 13F holders of RARE Full Q3 2023 holdings

Shares (Q3 2023): 215,000
Value: $7.66M
% of portfolio: 3.0%
Quarters held: 3; Since Q1 2021

Holdings of RARE by CHI Advisors LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q3 2023	215,000	$7.66M	3.0%	+130,000+152.9%	Added	Holders
Q2 2023	85,000	$3.92M	1.2%	+85,000	New	Holders
Q2 2021	0	$0	0.0%	−2,000−100.0%	Sold out	Holders
Q1 2021	2,000	$228.0K	<0.1%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.